Rosukem Training Program

​Rosukem Training Program

07 December 2022

Multiple Choice

Mr. Ramanujan has LDL 280 mg/dl and TG 500 mg/dl. Which type of dyslipidemia he has been diagnosed?

• Hypertriglyceridemia

• Hypercholesterolemia

• Mixed dyslipidemia

Multiple Choice

Rosuvastatin is ______

• HMG CoA reductase inhibitor

• Cholesterol absorption inhibitor

• PCS K9 inhibitor

• Fibric acid derivative

Multiple Choice

Rosuvastatin causes _____in fibrous cap thickness

• Increase

• Decrease

• maintains

Multiple Choice

Rosuvastatin causes rapid and robust instability of plaque

• True

• False

Multiple Choice

Ezetimibe blocks absorption of cholesterol by blocking ________

• HMG CoA

• PPAR gamma

• NPC1L1

• PBP

Multiple Choice

Which of the following facts are correct for Ezetimibe?

• synergy to achieve LDL goals

• synergy to reduce inflammation burden

• More number of patients achieve LDL-C goals

• All of above